Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

53 results about "FAMILY ENTEROBACTERIACEAE" patented technology

Microorganism capable of producing l-amino acid, and method for production of l-amino acid

An L-amino acid can be produced by: culturing, in a culture medium, a microorganism belonging to the family Enterobacteriaceae which is capable of producing the L-amino acid and is modified so that the kdp system can be potentiated, thereby producing and accumulating the L-amino acid in the culture medium or a cell of the microorganism; and collecting the L-amino acid from the culture medium or the cell.
Owner:AJINOMOTO CO INC

Long chain dicarboxylic fatty acid (LCDFA) producing microbes and uses thereof

PendingCN112292141AOrganic active ingredientsOrganic chemistryMetaboliteGenus Faecalibacterium
A method for increasing gastric tract acid (GTA) production in a mammalian subject. The method comprises administering a therapeutically-effective amount of a composition comprising at least one liveor attenuated culture of a microbial species selected from the genus Blautia, species Faecalibacterium prausnitzii, genus Bacteroides, family Ruminococcaceae, family Lachnospiraceae, genus Coprococcus, genus Roseburia, genus Oscillospira, species Ruminococcus bromii, genus Ruminococcus, family Costridiaceae, species Dorea formicigenerans, species Bacteroides uniformis, genus Dorea, genus Streptococcus, order Clostridiales, genus Anaerostipes, genus Dialister, species Bifidobacterium adolescentis, family Coriobacteriaceae, genus Faecalibacterium, genus Sutterella, species Bacteroides ovatus, genus Parabacteroides, genus Ruminococcus, species Bacteroides faecis, species Eubacterium biforme, genus Phascolartobacterium, and family Enterobacteriaceae; or a prebiotic composition which increasesgrowth and / or viability of said microbial species in the gut. Administering the composition increases the synthesis of at least one GTA dicarboxylic fatty acid metabolite in said subject. Also described are method for determining gastrointestinal inflammation status and kits for detecting and treating a gastric tract acid (GTA) insufficiency.
Owner:医学生命探索有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products